Application of peptide-based matrix metalloproteinase inhibitors in corneal ulceration.
Gray
R D
RD
Department of Biochemistry, University of Louisville School of Medicine, Kentucky 40292.
Paterson
C A
CA
D000818:Animals; D002057:Burns, Chemical; D003320:Corneal Ulcer / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D004151:Dipeptides / Q000627:therapeutic use*; D004195:Disease Models, Animal; D015817:Eye Infections / Q000188:drug therapy* / Q000473:pathology; D007634:Keratitis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000473:pathology; D011817:Rabbits; D013997:Time Factors
D004151:Dipeptides; C075190:HSCH2CH(CH2CH(CH3)2)CO-Phe-Ala-NH2; D008666:Metalloendopeptidases